Current reports
6-K
Current report (foreign)
15 Apr 24
6-K
Current report (foreign)
13 Mar 24
6-K
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
23 Feb 24
6-K
Securities Purchase Agreement
6 Feb 24
6-K
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
1 Dec 23
6-K
Current report (foreign)
14 Nov 23
6-K
Current report (foreign)
1 Nov 23
6-K/A
Current report (foreign) (amended)
29 Aug 23
6-K
Current report (foreign)
16 Aug 23
6-K
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
11 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
1 Aug 23
424B5
Prospectus supplement for primary offering
12 Aug 22
424B5
Prospectus supplement for primary offering
22 Oct 21
POS AM
Prospectus update (post-effective amendment)
18 Oct 21
POS AM
Prospectus update (post-effective amendment)
15 Oct 21
F-3
Shelf registration (foreign)
15 Oct 21
424B4
Prospectus supplement with pricing info
12 Apr 21
424B4
Prospectus supplement with pricing info
12 Apr 21
POS AM
Prospectus update (post-effective amendment)
8 Apr 21
POS AM
Prospectus update (post-effective amendment)
8 Apr 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
25 Oct 21
EFFECT
Notice of effectiveness
21 Oct 21
EFFECT
Notice of effectiveness
21 Oct 21
CORRESP
Correspondence with SEC
20 Oct 21
UPLOAD
Letter from SEC
20 Oct 21
EFFECT
Notice of effectiveness
9 Apr 21
EFFECT
Notice of effectiveness
9 Apr 21
EFFECT
Notice of effectiveness
15 Mar 21
CORRESP
Correspondence with SEC
11 Mar 21
UPLOAD
Letter from SEC
9 Mar 21
Ownership
SC 13D/A
Griffiths Richard Ian
27 Mar 24
SC 13G/A
Lombard Odier Asset Management (USA) Corp
14 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G/A
GOLDMAN SACHS GROUP INC
12 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G
Artal International S.C.A.
1 Sep 23
SC 13D/A
Griffiths Richard Ian
14 Aug 23
SC 13G/A
TCG Crossover GP I, LLC
14 Feb 23
SC 13G/A
Lombard Odier Asset Management (USA) Corp
14 Feb 23
SC 13G/A
GOLDMAN SACHS GROUP INC
8 Feb 23